Meprobamate recalls
The FDA has published 2 recalls involving Meprobamate since 2013. The latest was reported on 27 Mar 2013. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2013
Last 12 months0reported
Class I00% of total
Ongoing0latest 27 Mar 2013
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why meprobamate is recalled
Companies
By year
All meprobamate recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Meprobamate; Tablets USP, 400 mg recalled by Watson Laboratories | Watson Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Meprobamate, Tablets USP, 200 mg recalled by Watson Laboratories | Watson Laboratories | Potency & Assay | Nationwide |
Should you stop taking Meprobamate?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.